Levi & Korsinsky, LLP announces that a TCDA class action lawsuit has been commenced on behalf of investors who purchased Tricida, Inc. (TCDA) securities between September 4, 2019 and October 28, 2020. For more on the Tricida Class Action please contact us today.

According to the Interface lawsuit, throughout the Class Period defendants made false and/or misleading statements and/or failed to disclose that: (i) Tricida’s NDA for veverimer was materially deficient; (ii) accordingly, it was foreseeably likely that the FDA would not accept the NDA for veverimer; and (iii) as a result, the Company’s public statements were materially false and misleading at all relevant times.

TO LEARN MORE ABOUT THE TCDA CLASS ACTION, CLICK HERE

If you suffered a loss in Interface you have until March 8, 2021 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn’t require that you serve as a lead plaintiff.

CONTACT:

Levi & Korsinsky, LLP

Joseph E. Levi, Esq.

55 Broadway, 10th Floor

New York, NY 10006

jlevi@levikorsinsky.com

Tel: (212) 363-7500

Fax: (212) 363-7171

www.zlk.com